Coverage
Filings
Genmab A/S announced encouraging results from its Phase 1/2 RAINFOL-01 trial for rinatabart sesutecan (Rina-S), an investigational antibody-drug conjugate (ADC), in heavily pretreated patients with advanced endometrial cancer.
| 4 Mar 2009 |
| Genmab to Attend Two March Investor Conferences | 26 Feb 2009 |
| Arzerra(TM) (ofatumumab) MAA Accepted by EMEA | 26 Feb 2009 |
| Financial Statements Release 2008 | 24 Feb 2009 |
| Genmab Announces Year End 2008 Financial Results | 24 Feb 2009 |